Sath Shukla serves as Executive at ZIOPHARM ONCOLOGY INC, where they oversee executive responsibilities. Since joining the company, Sath Shukla has executed 15 insider transactions totaling $184.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 27, 2024 involved selling 2,757 shares valued at $3.7K.
Sath Shukla currently holds 1,140,809 shares of ZIOPHARM ONCOLOGY INC (ZIOP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sath Shukla has been a net seller of ZIOP stock. They have purchased $0 and sold $184.6K worth of shares.
Sath Shukla's most recent insider trade was on Aug 27, 2024, when they sold 2,757 shares at $1.35 per share.
Get notified when new Form 4 filings are submitted
| $1.31 |
| Discretionary |
| Aug 2, 2024 | SPRO | $19.5K | Sale | 14,800 | $1.32 | Discretionary |
| Feb 5, 2024 | SPRO | $65.4K | Sale | 45,093 | $1.45 | Planned |
| Feb 2, 2024 | SPRO | $42.3K | Sale | 30,901 | $1.37 | Planned |
| Feb 1, 2024 | SPRO | $0 | Award | 679,501 | $N/A | Planned |
| Aug 29, 2023 | SPRO | $5.4K | Sale | 4,163 | $1.30 | Planned |
| Aug 28, 2023 | SPRO | $2.3K | Sale | 1,854 | $1.26 | Planned |
| Aug 1, 2023 | SPRO | $0 | Award | 266,000 | $N/A | Discretionary |
| Feb 2, 2023 | SPRO | $17.4K | Sale | 9,504 | $1.83 | Discretionary |
| Feb 1, 2023 | SPRO | $0 | Award | 265,957 | $N/A | Discretionary |
| Aug 29, 2022 | SPRO | $5.4K | Sale | 6,017 | $0.89 | Discretionary |
| Feb 1, 2022 | SPRO | $0 | Award | 38,014 | $N/A | Discretionary |
| Aug 26, 2021 | SPRO | $0 | Award | 24,067 | $N/A | Discretionary |
| Jan 29, 2020 | ZIOP | $0 | Award | 80,500 | $N/A | Discretionary |